Net Asset Value(s)

RNS Number : 9245M
Port Erin Biopharma Investments Ltd
22 July 2014
 



For immediate release                                                                                                                                 22 July 2014

Port Erin Biopharma Investments Limited

 (the "Company")

Net Asset Value calculation to 30 June 2014

Jim Mellon, Chairman, commented: -

"The Net Asset Value ("NAV") calculation for the Company as at closing on 30 June 2014 was 14.71 pence per share, including un-invested cash of £526,503 and an accrual carried forward of £379,057 for the management fee. The portfolio is valued under IFRS at bid price.

Thus in the full year, Total Assets have grown in value by 37.1% to just under £5.0 million, and Investments have grown in value by 65.6% to £4.8 million. This quarter's NAV represents a decrease of 4.5% from the previous valuation of 15.40 pence per share, which included un-invested cash of £736,392. On this basis, no additional management fee is due to Shellbay Investments Limited.

Our holding in the Magna Biopharma Income Fund continues to perform well, the value having risen by 7.0% to £2.9 million in the six months since inception."


 

Unaudited

to 30 June 2014

£

Fixed Assets

 

 

 

Investments

 

4,830,908

 

Current Assets

 

 

 

Debtors: amounts owing

24,997

 

Un-invested cash

 

526,503

 

Current Liabilities

 

 

 

Creditors: amounts due

 

(400,982)

 

 

 

4,981,426

 

Capital and Reserves

 

 

 

Share Capital

34

 

Share Premium

2,759,551

 

Current year's earnings

1,381,475

 

Retained earnings

 

840,366

 


4,981,426

 



 

Shares in Issue

 


33,864,836

Asset Value per share


14.71 pence



 

--- ENDS ---

Portfolio Details

Investments as at 30 June 2014

Value

% of Total Portfolio




Magna Biopharma Income Fund

£2,901,683

60.06%

Plethora Solutions Holdings

£852,500

17.65%

Summit Corporation

£536,667

11.11%

Other quoted holdings

£163,938

3.39%

Other unquoted holdings

£376,120

7.79%

 

Total

 

 £4,830,908

100.00% 

 

For further information, please contact:

Port Erin Biopharma Investments Limited

Beaumont Cornish Limited

Peterhouse Capital Limited

The Company

Nomad

Broker




Denham Eke

+44 162 463 9396

Roland Cornish

+44 207 628 3396

Jon Levinson

+44 207 469 0935

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVGMGZNLMZGDZM
UK 100